FEN1 and malignant colon neoplasm: Under unperturbed conditions, CRISPR-Cas9 knocking out FEN1 in the HT29 colon cancer cell line led to an increase in the levels of DPCs in comparison with the isogenic WT cells (1.205 ± 0.115, P = 0.017; fig.